Novel NADPH oxidase inhibitor VAS2870 suppresses TGF‑β‑dependent epithelial‑to‑mesenchymal transition in retinal pigment epithelial cells

Yang,Jing; Li,Jing; Wang,Qun; Xing,Yao; Tan,Zizhu; Kang,Qianyan

doi:10.3892/ijmm.2018.3612

Novel NADPH oxidase inhibitor VAS2870 suppresses TGF‑β‑dependent epithelial‑to‑mesenchymal transition in retinal pigment epithelial cells

Authors:
- Jing Yang
- Jing Li
- Qun Wang
- Yao Xing
- Zizhu Tan
- Qianyan Kang
View Affiliations

Affiliations: Department of Ophthalmology, The First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Ophthalmology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China, Department of Ophthalmology, The First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: April 3, 2018 https://doi.org/10.3892/ijmm.2018.3612
Pages: 123-130
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

NADPH oxidases (NOXs) are important in the pathophysiology of fibrotic diseases. The expression and activity of NOXs are regulated by growth factors, including transforming growth factor (TGF‑β). The proliferation of retinal pigment epithelial (RPE) cells following epithelial‑ to‑mesenchymal transition (EMT) is a major pathological change involved in proliferative vitreoretinopathy (PVR). The aim of the present study was to determine the effects of the novel NOX inhibitor VAS2870 on the TGF‑β‑dependent expression of NOX4 and associated cellular events in RPE cells. Cell viability was examined using a Cell Counting Kit‑8 assay and cell cycle progression was detected by flow cytometric analysis. Immunofluorescence analysis and western blot analysis were performed to assess EMT. It was found that TGF‑β increased the expression of NOX4 and that pre‑incubation with VAS2870 eliminated this effect. Additionally, TGF‑β promoted RPE migration and increased EMT. Pre‑incubation with VAS2870 significantly prevented TGF‑β2‑induced EMT by decreasing the levels of α‑smooth muscle actin and E‑cadherin, and also inhibited the migratory ability of the RPE cells, as demonstrated by scratch assays. Finally, VAS2870 suppressed the proliferation of RPE cells, and led to G1‑phase cell cycle arrest and a significant downregulation of the expression of cyclin D1. In conclusion, the pharmacological inhibition of NOX may be a promising tool for the treatment of PVR.

View Figures

View References

1	Ho PC and McMeel JW: Retinal detachment with proliferative vitreoretinopathy: Surgical results with scleral buckling, closed vitrectomy, and intravitreous air injection. Br J Ophthalmol. 69:584–587. 1985. View Article : Google Scholar : PubMed/NCBI
2	Kroll P, Rodrigues EB and Hoerle S: Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica. 221:78–94. 2007. View Article : Google Scholar : PubMed/NCBI
3	Tosi GM, Marigliani D, Romeo N and Toti P: Disease pathways in proliferative vitreoretinopathy: An ongoing challenge. J Cell Physiol. 229:1577–1583. 2014. View Article : Google Scholar : PubMed/NCBI
4	Cui JZ, Chiu A, Maberley D, Ma P, Samad A and Matsubara JA: Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy. Eye. 21:200–208. 2007. View Article : Google Scholar
5	Pastor JC, de la Rúa ER and Martín F: Proliferative vitreoretinopathy: Risk factors and pathobiology. Prog Retin Eye Res. 21:127–144. 2002. View Article : Google Scholar : PubMed/NCBI
6	Grisanti S and Guidry C: Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci. 36:391–405. 1995.PubMed/NCBI
7	Pennock S, Haddock LJ, Eliott D, Mukai S and Kazlauskas A: Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy. Prog Retin Eye Res. 40:16–34. 2014. View Article : Google Scholar : PubMed/NCBI
8	Lassègue B: Clempus RE. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am J Physiol Regul. Integr Comp Physiol. 285:R277–R297. 2003. View Article : Google Scholar
9	Brown DI and Griendling KK: Nox proteins in signal transduction. Free Radic Biol Med. 47:1239–1253. 2009. View Article : Google Scholar : PubMed/NCBI
10	Kita T, Hata Y, Kano K, Miura M, Nakao S, Noda Y, Shimokawa H and Ishibashi T: Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: Possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes. 56:231–238. 2007. View Article : Google Scholar
11	Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
12	Qiu Y, Tao L, Lei C, Wang J, Yang P, Li Q and Lei B: Downregulating p22phox ameliorates inflammatory response in Angiotensin II-induced oxidative stress by regulating MAPK and NF-κB pathways in ARPE-19 cells. Sci Rep. 5:143622015. View Article : Google Scholar
13	Kim JH, Park S, Chung H and Oh S: Wnt5a attenuates the pathogenic effects of the Wnt/beta-catenin pathway in human retinal pigment epithelial cells via down-regulating β-catenin and Snail. BMB Rep. 48:525–530. 2015. View Article : Google Scholar : PubMed/NCBI
14	Michaeloudes C, Sukkar MB, Khorasani NM, Bhavsar PK and Chung KF: TGF-β regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 300:L295–L304. 2011. View Article : Google Scholar
15	Li S, Tabar SS, Malec V, Eul BG, Klepetko W, Weissmann N, Grimminger F, Seeger W, Rose F and Hänze J: NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid Redox Signal. 10:1687–1698. 2008. View Article : Google Scholar : PubMed/NCBI
16	Pan X, Dai Y, Li X, Niu N, Li W, Liu F, Zhao Y and Yu Z: Inhibition of arsenic-induced rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-β/Smad activation. Toxicol Appl Pharmacol. 254:323–331. 2011. View Article : Google Scholar : PubMed/NCBI
17	Lapperre TS, Jimenez LA, Antonicelli F, Drost EM, Hiemstra PS, Stolk J, MacNee W and Rahman I: Apocynin increases glutathione synthesis and activates AP-1 in alveolar epithelial cells. FEBS Lett. 443:235–239. 1999. View Article : Google Scholar : PubMed/NCBI
18	Engels F, Renirie BF, Hart BA, Labadie RP and Nijkamp FP: Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett. 305:254–256. 1992. View Article : Google Scholar : PubMed/NCBI
19	Majander A, Finel M and Wikström M: Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J Biol Chem. 269:21037–21042. 1994.PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔ^C^T method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Ishikawa K, He S, Terasaki H, Nazari H, Zhang H, Spee C, Kannan R and Hinton DR: Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy. Sci Rep. 5:163862015. View Article : Google Scholar : PubMed/NCBI
22	ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Bäumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H and Rosenkranz S: Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res. 71:331–341. 2006. View Article : Google Scholar : PubMed/NCBI
23	Boudreau HE, Casterline BW, Burke DJ and Leto TL: Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells. Br J Cancer. 110:2569–2582. 2014. View Article : Google Scholar :
24	Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, Page P, Sutliff RL and Hart CM: The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol. 47:718–726. 2012. View Article : Google Scholar : PubMed/NCBI
25	Martin-Garrido A, Brown DI, Lyle AN, Dikalova A, Seidel-Rogol B, Lassègue B, San Martín A and Griendling KK: NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor. Free Radic Biol Med. 50:354–362. 2011. View Article : Google Scholar
26	Tobar N, Toyes M, Urra C, Méndez N, Arancibia R, Smith PC and Martínez J: c-Jun N terminal kinase modulates NOX-4 derived ROS production and myofibroblasts differentiation in human breast stromal cells. BMC Cancer. 14:6402014. View Article : Google Scholar : PubMed/NCBI
27	Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, et al: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53:1696–1701. 1993.PubMed/NCBI
28	Li H, Wang H, Wang F, Gu Q and Xu X: Snail involves in the trans forming growth factor β1-mediated epithelial-mesenchymal tran sition of retinal pigment epithelial cells. PLoS One. 6:e233222011. View Article : Google Scholar
29	Palma-Nicolás JP and López-Colomé AM: Trombin induces slug-mediated E-cadherin transcriptional repression and the parallel up-regulation of N-cadherin by a transcription-independent mechanism in RPE cells. J Cell Physiol. 228:581–589. 2013. View Article : Google Scholar
30	Zhang LL, Huang S, Ma XX, Zhang WY, Wang D, Jin SY, Zhang YP, Li Y and Li X: Angiotensin(1-7) attenuated angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H₂O₂-activated NLRP3 inflammasome/IL-1β/Smad circuit. Free Radic Biol Med. 97:531–543. 2016. View Article : Google Scholar : PubMed/NCBI
31	Das SJ, Lovicu FJ and Collinson EJ: Nox4 plays a role in TGF-β-dependent lens epithelial to mesenchymal transition. Invest Ophthalmol Vis Sci. 57:3665–3673. 2016. View Article : Google Scholar : PubMed/NCBI
32	Abrigo J, Morales MG, Simon F, Cabrera D, Di Capua G and Cabello-Verrugio C: Apocynin inhibits the upregulation of TGF-β1 expression and ROS production induced by TGF-β in skeletal muscle cells. Phytomedicine. 22:885–893. 2015. View Article : Google Scholar : PubMed/NCBI
33	Sancho P and Fabregat I: The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells. Biochem Pharmacol. 81:917–924. 2011. View Article : Google Scholar : PubMed/NCBI
34	Boudreau HE, Casterline BW, Rada B, Korzeniowska A and Leto TL: Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells. Free Radic Biol Med. 53:1489–1499. 2012. View Article : Google Scholar : PubMed/NCBI
35	Ge A, Ma Y, Liu YN, Li YS, Gu H, Zhang JX, Wang QX, Zeng XN and Huang M: Diosmetin prevents TGF-β1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways. Life Sci. 153:1–8. 2016. View Article : Google Scholar : PubMed/NCBI